N&PD Moderators: Skorpio
You should upgrade or use an alternative browser.(S)-N-Methyl-N-(3-Methyl-1-(1-pyrrolidin-yl)butyl-2)-2-phenoxyacetomide
Hammilton
Bluelighter
if it's a kappa agonist why in fucks name would you want to take it? take dysphoric salvia and drag it out a couple hours. they're awful, awful drugs, hardly recreational!
unless you want it because it'd be a cool chemical to own, and collect, of course. It's one I'd like in my collection- but only for the sake of saying, look at this!Slapdragonx
Bluelighter
[1]:
RJ, Russell K, Shaw JS. Structure/activity studies related to
2-(3,4-dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted-
ethyl]acetamides: a novel series of potent and selective kappa-opioid agonists. J Med Chem. 1991 Nov;34(11):3149-58. PubMed PMID: 1659636.
hamhurricane
Bluelighter
Can anyone post the structure to this compound?MurphyClox
Bluelighter
"(S)-N-Methyl-N-(3-Methyl-1-(1-pyrrolidin-yl)butyl-2)-2-phenoxyacetomide"
I believe the structure you posted is:
N-Methyl-N-[3-Methyl-2-(1-pyrrolidinyl)butyl]-2-phenoxyacetamidedread
Bluelighter
Thus, 3-methyl-1-pyrrolidinyl-butan-2-yl.
The pyrrolidine is connected to the end of the butane chain so it must be either 1 or 4.
thusly:
MurphyClox
Bluelighter
Yep, I used the name from the thread-title, too.
vs.
N-Methyl-N-[3-Methyl-2-(1-pyrrolidinyl)butyl]-2-phenoxyacetamide
Let's forget any typos a lá "...acetomide", but only focus on what I marked in blue. The 2 names that you provided describe the same molecule, which is the one shown in my last post ![]()
I admit, the given name do not fit entirely valid rules for organic nomenclature; it must be either "...2-butyl)" or "...but-2-yl)", but not "...butyl-2)".
Peace! - Murphy
P.S. I just love the way Dread annoted my scheme. Epic!!! 
thesomoan
Bluelighter
I've never had much of an enjoyable experience with salvia... but it looks quite interesting.
Does anybody have an idea of the active dosage?
P.S. I'm still greenlighter status, so I can't reply to private msgs yet.